Hernández-Sánchez, MaríaKotaskova, JanaRodríguez, Ana E.Radova, LenkaTamborero Noguera, DavidAbáigar, MaríaPlevova, KarlaBenito, RocíoTom, NikolaQuijada-Álamo, MiguelBikos, VasileosMartín, Ana ÁfricaPal, KarolGarcía de Coca, AlfonsoDoubek, MichaelLópez Bigas, NúriaHernández-Rivas, Jesús MaríaPospisilova, Sarka2019-06-112019-06-112019Hernández-Sánchez M, Kotaskova J, Rodríguez AE, Radova L, Tamborero D, Abáigar M. et al. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase. Leukemia. 2019 Feb;33(2):518-558. DOI: 10.1038/s41375-018-0255-10887-6924http://hdl.handle.net/10230/41729application/pdfengThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/Leucèmiainfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1038/s41375-018-0255-1info:eu-repo/semantics/openAccess